CA2788963A1 — Push rod activated medicated module
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2011-08-11 · 15y expired
What this patent protects
A medicated module (200)for an injection system to co-deliver at least two medicaments is disclosed. The drug delivery device (100)includes a push rod (400) operably connected to a dose dial button (113).The medicated module (200) includes a housing (202)having a connector config…
USPTO Abstract
A medicated module (200)for an injection system to co-deliver at least two medicaments is disclosed. The drug delivery device (100)includes a push rod (400) operably connected to a dose dial button (113).The medicated module (200) includes a housing (202)having a connector configured for attachment to the drug delivery device (100), and the housing (202) is configured to receive a portion of the push rod (400) when the medicated module (200)is attached to the drug delivery device (100). The medicated module (200) further includes a reservoir (302) in the housing (202) comprising a single dose of a medicament(300)and a needle guard (216) operably connected to the housing (202) and configured to move in an axial direction (218) during application to an injection site. Still further, the medicated module (200) includes a sleeve (220) in the housing (202) configured to move axially in the housing (202) and a locking collar (223) in the housing (202) configured to move axially and rotationally in the housing (202).
Drugs covered by this patent
- Glucagen (GLUCAGON) · Xeris
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.